Professor of Medical Oncology, University KY College of Medicine
Hematology
Dr. Edward H. Romond, MD
|
|
Give Review
Doctor Edward H. Romond, MD practices Hematology. He graduated from University of Kentucky College of Medicine. University of Kentucky College of Medicine is ranked 63 in research and 72 in primary care medicine He received awards:"America's Top Doctors" and "America's Top Doctors for Cancer". Edward Romond is a published MD. He published 48 publications, including: 'Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.
- Body mass index at diagnosis and breast Cancer survival prognosis in clinical trial populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38.
- Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 ...
- Impact of estrogen receptor (ER) and human epidermal growth factor receptor-2 (HER2) co-expression on breast Cancer disease characteristics: implications for tumor bio...
- Everolimus-Induced Hematologic Changes in Patients With Metastatic Breast Cancer.
- Metastatic angiosarcoma and kasabach-merritt syndrome.
- Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast Cancer.
- A phase II study of combined fulvestrant and everolimus in patients with metastatic estrogen receptor (ER)-positive breast Cancer after aromatase inhibitor (AI) failure.
- Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31.
- Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP ...
- A prognostic model of early breast Cancer relapse after standard adjuvant therapy and comparison with metastatic disease on initial presentation.
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Joint Analysis of Data From...
- Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast Cancer.
- Size of sentinel node tumor deposits and extent of axillary lymph node involvement: which breast Cancer patients may benefit from less aggressive axillary dissections?
- Ultrasound-guided fine-needle aspiration of clinically negative lymph nodes versus sentinel node mapping in patients at high risk for axillary metastasis.
- Advances in adjuvant therapy for breast Cancer.
- Assessment of cardiac dysfunction in a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel, with or without trastuzumab as adjuvant ther...
- Real-world performance of HER2 testing--National Surgical Adjuvant Breast and Bowel Project experience.
- Should Histologic Grade Be Incorporated into the TNM Classification System for Small (T1, T2) Node-Negative Breast Adenocarcinomas?
- Clinical updates on EGFR/HER targeted agents in early-stage breast Cancer.
- Intratumoral deLivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations.
- Distinct lymph nodal sonographic characteristics in breast Cancer patients at high risk for axillary metastases correlate with the final axillary stage.
- The critical role of axillary ultrasound and aspiration biopsy in the management of breast Cancer patients with clinically negative axilla.
- Palliative chemotherapy and hormonal therapy.
- Effects of chronic rotation and hypergravity on muscle fibers of soleus and plantaris muscles of the rat.
- Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast Cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.
- Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project P...
- Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast Cancer: findings from National Surgical Adjuvant Bre...
- The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I.
- Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.
- Lymphocyte infusion for delayed extramedullary relapse of Acute leukemia following bone marrow transplantation.
- Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast Cancer: findings from Nation...
- Treatment of Leukemia with partially matched related bone marrow transplantation.
- Long-term survival in advanced chronic myelogenous Leukemia following bone marrow transplantation from haploidentical related donors.
- Allogeneic bone marrow transplantation with T cell-depleted partially matched related donors for advanced Acute lymphoblastic leukemia in children and adults: a compar...
- Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host Disease following haploidentical marrow transplant.
- Pancreatic islet cell Carcinoma associated with multiple hormone secretion and pancytopenia. Evidence of a serum factor suppressing hematopoiesis.
- Catabolism and distribution of functionally heterogeneous human antithrombin III.
- T cell depletion of HLA and haploidentical marrow reduces graft-versus-host disease but it may impair a graft-versus-Leukemia effect.
- Positive antiglobulin tests due to intravenous immunoglobulin in patients who received bone marrow transplant.
- Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host Disease: importance of limiting dilution ana...
- Control of Oral mucositis and candidiasis in marrow transplantation: a prospective, double-blind trial of chlorhexidine digluconate Oral rinse.
- A new approach to the prevention of graft-versus-host Disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
- Immunophenotyping of peripheral blood lymphocytes in the diagnosis of Acute graft-versus-host disease.
- Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.
- Patients' knowledge of their caregivers' names. A teaching-hospital study.
- ERBB2 (HER2) Testing in Breast Cancer.
Schools
University Of Kentucky
Mi State University Clinical Center
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
University of Kentucky College of Medicine
Hospital
-
University of Kentucky Albert B. Chandler Hospital
Drug Facts
| NPI NUMBER | 1083633572 | |
| NPPES Provider LastName | ROMOND | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 405360001 | |
| NPPES Provider State | KY | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 1239.0 | |
| Distinct Opioid Count | 6.0 | |
| Opioid Claim Count | 175.0 | |
| Percent Opioid Claims | 14.12 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083633572 |
| Last Name Of The Provider | ROMOND |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Julie A. Ribes, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shams A. Shakil, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Firas B. Badin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susanne M. Arnold, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jessica J. Moss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dianna S. Howard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zartash Gul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John W. Hayslip, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana A. Johnson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lawrence C. Maguire, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Milton O. Nelson Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John J. Rinehart, MD |
|
|
Dr. Gregory P. Monohan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Phillip A. Desimone, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John L. Villano, MD
This Doctor is OpenDoctor Recommended.
|